Interferon regulatory factor 4 plays a pivotal role in the development of aGVHD-associated colitis-Reference-Cited by-同舟云学术

Interferon regulatory factor 4 plays a pivotal role in the development of aGVHD-associated colitis

Published:2023-12-27 Issue:1 Volume:13 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Frueh Jochen T.¹²,Campe Julia¹²,Sunaga-Franze Daniele Yumi³,Verheyden Nikita A.⁴⁵,Ghimire Sakhila⁶,Meedt Elisabeth⁶,Haslinger Denise⁷,Harenkamp Sabine⁸,Staudenraus Daniel⁹,Sauer Sascha³,Kreft Andreas¹⁰,Schubert Ralf¹¹,Lohoff Michael⁹,Krueger Andreas⁴⁵¹²,Bonig Halvard⁸¹³,Chiocchetti Andreas G.⁷,Zeiser Robert¹⁴,Holler Ernst⁶,Ullrich Evelyn¹²¹³¹⁵¹⁶^ORCID

Affiliation:

1. Department of Pediatrics, Experimental Immunology and Cell Therapy, Goethe University Frankfurt, Frankfurt am Main, Germany

2. Department of Pediatrics, Goethe University Frankfurt, University Hospital, Frankfurt am Main, Germany

3. Genomics Platform, Max Delbrueck Center for Molecular Medicine, Berlin Institute of Health, Berlin, Germany

4. Institute for Molecular Medicine, University Hospital, Goethe University Frankfurt, Frankfurt, Germany

5. Molecular Immunology, Justus Liebig University Giessen, Giessen, Germany

6. Hematology and Oncology Department, Medical Clinic 3, University Hospital Regensburg, Regensburg, Germany

7. Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, Goethe University Frankfurt, University Hospital, Frankfurt am Main, Germany

8. German Red Cross Blood Service BaWüHe, Frankfurt am Main, Germany

9. Institute for Microbiology, Philipps University, Marburg, Germany

10. Institute of Pathology, University Medical Center Mainz, Mainz, Germany

11. Department of Pediatric Medicine, Division of Pneumology, Allergology, Infectious diseaes und Gastroenterology. Frankfurt am Main, Goethe University Frankfurt, Frankfurt, Germany

12. Frankfurt Cancer Institute (FCI), Goethe University, Frankfurt am Main, Germany

13. Institute for Transfusion Medicine and Immunohematology, Goethe University, Frankfurt am Main, Germany

14. Department of Internal Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany

15. German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, a partnership between DKFZ, University Hospital Frankfurt, Frankfurt, Germany

16. University Cancer Center (UCT), Frankfurt am Main, Germany

Funder

Hessian Ministry of Higher Education, Research and the Arts, Germany

Max-Eder Research Program of the German Cancer Aid

Adolf Messer Foundation (E.U.) and the Wilhelm Sander Foundation

IRTG of the Collaborative Research Center

Deutsche Forschungsgemeinschaft

DFG

Jose-Carreras Leukemia foundation

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2023.2296712

Reference65 articles.

1. Long-Term Survival and Late Deaths After Allogeneic Hematopoietic Cell Transplantation

2. Prognostic factors for survival of patients with newly diagnosed chronic GVHD according to NIH criteria

3. Longitudinal Assessment of Morbidity and Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation: Retrospective Analysis of a Multicenter Phase III Study

4. Risk factors for acute GVHD and survival after hematopoietic cell transplantation

5. Long-Term Morbidity and Mortality in Children with Chronic Graft-versus-Host Disease Classified by National Institutes of Health Consensus Criteria after Allogeneic Hematopoietic Stem Cell Transplantation